» Articles » PMID: 39064610

Current Opinion on Diagnosis of Peripheral Artery Disease in Diabetic Patients

Overview
Publisher MDPI
Specialty General Medicine
Date 2024 Jul 27
PMID 39064610
Authors
Affiliations
Soon will be listed here.
Abstract

Peripheral arterial disease (PAD) prevalence and diabetes mellitus (DM) prevalence are continuously increasing worldwide. The strong relationship between DM and PAD is highlighted by recent evidence. PAD diagnosis in diabetic patients is very important, particularly in patients with diabetic foot disease (DFD); however, it is often made difficult by the characteristics of such diseases. Diagnosing PAD makes it possible to identify patients at a very high cardiovascular risk who require intensive treatment in terms of risk factor modification and medical therapy. The purpose of this review is to discuss the diagnostic methods that allow for a diagnosis of PAD in diabetic patients. Non-invasive tests that address PAD diagnosis will be discussed, such as the ankle-brachial index (ABI), toe pressure (TP), and transcutaneous oxygen pressure (TcPO2). Furthermore, imaging methods, such as duplex ultrasound (DUS), computed tomography angiography (CTA), magnetic resonance angiography (MRA), and digital subtraction angiography (DSA), are described because they allow for diagnosing the anatomical localization and severity of artery stenosis or occlusion in PAD. Non-invasive tests will also be discussed in terms of their ability to assess foot perfusion. Foot perfusion assessment is crucial in the diagnosis of critical limb ischemia (CLI), the most advanced PAD stage, particularly in DFD patients. The impacts of PAD diagnosis and CLI identification in diabetic patients are clinically relevant to prevent amputation and mortality.

Citing Articles

Evaluation of wound temperature monitoring at various anatomical sites in the management of patients with diabetic foot undergoing microcirculation reconstruction.

Liu H, Yan X, Li G, Wang B, Wang D, Zhang Y J Orthop Surg Res. 2024; 19(1):776.

PMID: 39568046 PMC: 11577819. DOI: 10.1186/s13018-024-05278-7.


Neutrophil-to-lymphocyte ratio in type 2 diabetes patients combined with Lower Extremity Peripheral Artery Disease.

Li L, Wang M, Jia T, Jiang X, Yang F, Wang Z Front Endocrinol (Lausanne). 2024; 15:1434580.

PMID: 39280000 PMC: 11392728. DOI: 10.3389/fendo.2024.1434580.

References
1.
Gerhard-Herman M, Gornik H, Barrett C, Barshes N, Corriere M, Drachman D . 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2016; 69(11):e71-e126. DOI: 10.1016/j.jacc.2016.11.007. View

2.
Tehan P, Barwick A, Sebastian M, Chuter V . Diagnostic accuracy of resting systolic toe pressure for diagnosis of peripheral arterial disease in people with and without diabetes: a cross-sectional retrospective case-control study. J Foot Ankle Res. 2017; 10:58. PMC: 5735897. DOI: 10.1186/s13047-017-0236-z. View

3.
. Global burden of peripheral artery disease and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Glob Health. 2023; 11(10):e1553-e1565. PMC: 10522777. DOI: 10.1016/S2214-109X(23)00355-8. View

4.
Beckman J, Creager M, Libby P . Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA. 2002; 287(19):2570-81. DOI: 10.1001/jama.287.19.2570. View

5.
Santoro L, Flex A, Nesci A, Ferraro P, De Matteis G, Di Giorgio A . Association between peripheral arterial disease and cardiovascular risk factors: role of ultrasonography versus ankle-brachial index. Eur Rev Med Pharmacol Sci. 2018; 22(10):3160-3165. DOI: 10.26355/eurrev_201805_15076. View